---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-002292"
form_type: "8-K"
ticker: "XAIR"
cik: "0001641631"
company_name: "Beyond Air, Inc."
filed_at: "2026-01-15T23:59:59+00:00"
generated_at: "2026-05-16T10:08:50.024995+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# XTL to acquire 85% of Beyond Air's NeuroNOS for equity, $1M cash, up to $32.5M milestones

## Summary
- XTL acquires 85% of NeuroNOS for 19.9% of XTL's share capital, $1M cash, and up to $32.5M in milestone payments.
- NeuroNOS platform targets core autism pathophysiology; two Nobel Laureates join scientific team.
- NeuroNOS holds two FDA Orphan Drug Designations for Phelan-McDermid Syndrome and Glioblastoma.
- Beyond Air becomes significant XTL shareholder, retains 15% of NeuroNOS; deal valued up to $32.5M.

## SEC filing metadata
- accession: 0001493152-26-002292
- form_type: 8-K
- ticker: XAIR
- cik: 0001641631
- company_name: Beyond Air, Inc.
- filed_at: 2026-01-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641631/000149315226002292/0001493152-26-002292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641631/000149315226002292/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-002292
- JSON: https://secwatch.observer/filing/0001493152-26-002292.json
- Plain text: https://secwatch.observer/filing/0001493152-26-002292.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.